About OptiBiotix Health
OptiBiotix Health is a company based in York (United Kingdom) founded in 2012.. OptiBiotix Health offers products and services including SlimBiome, CholBiome, SweetBiotix, and WellBiome. OptiBiotix Health operates in a competitive market with competitors including Rhythm Pharmaceuticals, MannKind Corp, NGM Biopharmaceuticals, Corcept and Synlogic Therapeutics, among others.
- Headquarter York, United Kingdom
- Stage Public
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Optibiotix Health Plc
-
Annual Revenue
$1.09 M (USD)35.09as on Dec 31, 2024
-
Net Profit
$-2.26 M (USD)11.48as on Dec 31, 2024
-
EBITDA
$-2.58 M (USD)-38.59as on Dec 31, 2024
-
Latest Funding Round
$1.01 M (USD), Post-IPO
May 23, 2025
- Investors
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of OptiBiotix Health
OptiBiotix Health is a publicly listed company on the LSE with ticker symbol OPTI in UK, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Products & Services of OptiBiotix Health
OptiBiotix Health offers a comprehensive portfolio of products and services, including SlimBiome, CholBiome, SweetBiotix, and WellBiome. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Supplement modulating microbiome for weight control and health improvement.
Product for managing cholesterol through microbiome effects.
Alternative sweetener influencing microbiome for better health outcomes.
Formulation enhancing overall wellbeing via microbiome modulation.
Unlock access to complete
Unlock access to complete
Funding Insights of OptiBiotix Health
- Total Funding Total Funding
- Total Rounds 4
- Last Round Post-IPO — $1.0M
-
First Round
First Round
(05 Feb 2016)
- Investors Count 1
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| May, 2025 | Amount | Post-IPO - OptiBiotix Health | Valuation |
investors |
|
| May, 2018 | Amount | Post-IPO - OptiBiotix Health | Valuation |
investors |
|
| Jan, 2018 | Amount | Post-IPO - OptiBiotix Health | Valuation |
investors |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in OptiBiotix Health
OptiBiotix Health has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include Seneca EIS Portfolio Fund. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Private equity investment firm
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by OptiBiotix Health
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - OptiBiotix Health
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Optibiotix Health Comparisons
Competitors of OptiBiotix Health
OptiBiotix Health operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Rhythm Pharmaceuticals, MannKind Corp, NGM Biopharmaceuticals, Corcept and Synlogic Therapeutics, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Developer of peptide therapeutics for the treatment of rare genetic deficiencies
|
|
| domain | founded_year | HQ Location |
Developer of small-molecule drugs
|
|
| domain | founded_year | HQ Location |
Biologics are developed for cardio-metabolic and liver diseases.
|
|
| domain | founded_year | HQ Location |
Developer of cortisol modulators for the treatment of various diseases
|
|
| domain | founded_year | HQ Location |
Engineered microbes are developed as programmable therapeutics for metabolic disorders.
|
|
| domain | founded_year | HQ Location |
Pendulum is focused on developing advanced probiotic solutions.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Optibiotix Health
Frequently Asked Questions about OptiBiotix Health
When was OptiBiotix Health founded?
OptiBiotix Health was founded in 2012 and raised its 1st funding round 4 years after it was founded.
Where is OptiBiotix Health located?
OptiBiotix Health is headquartered in York, United Kingdom.
What is the annual revenue of OptiBiotix Health?
Annual revenue of OptiBiotix Health is $1.09M as on Dec 31, 2024.
What does OptiBiotix Health do?
OptiBiotix Health was founded in 2012 in York, United Kingdom. Microbial strains are developed for addressing human metabolic diseases in the biotechnology sector. Proprietary platforms, including OptiScreen and OptiBiotic, are used to pinpoint metabolic pathways and compounds that influence human physiology. These strains serve as food ingredients, supplements, or active compounds for managing obesity, cholesterol and lipid distribution, and diabetes.
Who are the top competitors of OptiBiotix Health?
OptiBiotix Health's top competitors include Rhythm Pharmaceuticals, MannKind Corp and Corcept.
What products or services does OptiBiotix Health offer?
OptiBiotix Health offers SlimBiome, CholBiome, SweetBiotix, and WellBiome.
Is OptiBiotix Health publicly traded?
Yes, OptiBiotix Health is publicly traded on LSE under the ticker symbol OPTI.
Who are OptiBiotix Health's investors?
OptiBiotix Health has 1 investor. Key investors include Seneca EIS Portfolio Fund.
What is OptiBiotix Health's ticker symbol?
The ticker symbol of OptiBiotix Health is OPTI on LSE.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.